Topics

5/24/18

UB’s Clinical and Translational Science Institute (CTSI) has awarded new grants that support promising translational research projects in Western New York.

4/18/18

Research led by senior author David Dietz, PhD, has revealed that in certain types of brain cells, drug-induced plasticity can work to reduce motivation for heroin.

3/22/18

A total of 37 original research projects from aspiring physician-scientists were on display at the 2018 Medical Student Research Forum.

1/10/18

The Western New York community has enlisted experts from the Jacobs School of Medicine and Biomedical Sciences to help combat the national opioid epidemic, which has reached crisis proportions.

12/11/17

The value of interprofessional collaboration in dealing with the opioid crisis was highlighted as students and staff from the Jacobs School of Medicine and Biomedical Sciences joined other UB schools of study during a forum on opioid dependence.

10/12/17

The Research Institute on Addictions (RIA) and faculty from the Jacobs School of Medicine and Biomedical Sciences (JSMBS) are leading an effort to combat the opioid crisis throughout the state.

5/3/17

UB researchers are developing innovative ways to better diagnose and treat hepatitis C virus (HCV) in people with substance abuse disorders.

1/31/17

Students from the Jacobs School of Medicine and Biomedical Sciences joined hundreds of their UB peers in the health professions, social work, law and management for an interprofessional forum on opioid dependence.

6/9/16

Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, has received a $7 million grant to develop an effective way to treat drug users with the hepatitis C virus (HCV).

5/2/16

Jun-Xu Li, MD, PhD, assistant professor of pharmacology and toxicology, has received the Joseph Cochin Young Investigator Award from the College of Problems of Drug Dependence (CPDD) for his research on pharmacotherapy for stimulant abuse.

4/6/16

According to a fact sheet released by the White House, the Jacobs School of Medicine and Biomedical Sciences is among medical schools nationwide at the forefront of fighting the opioid epidemic.

8/27/15

Researchers in the lab of David Dietz, PhD, assistant professor of pharmacology and toxicology, discovered an unknown neural pathway that can regulate changes made in the brain from cocaine use. 

8/13/15

Torin J. Finver, MD, program director for the Department of Family Medicine’s addiction medicine fellowship, has been appointed to the board of directors for the New York Society of Addiction Medicine (NYSAM).

9/19/14

Research by David Dietz, PhD, has the potential to identify novel therapies to treat addiction to cocaine and other psychostimulants, for which no effective drug therapy exists.

7/11/14

Research co-authored by Andrew H. Talal, MD, shows that injection drug users who are enrolled in a treatment program want to be educated about hepatitis C virus (HCV) and are willing to be treated.

3/7/14

The risks of the new painkiller Zohydro — an extended-release formulation of hydrocodone — far outweigh the benefits and could lead to more overdoses, according to Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine.

10/9/13

Richard D. Blondell, MD, vice chair for addiction medicine and professor of family medicine, will direct a new national center aimed at training physicians to address addiction through early intervention and prevention.

11/3/11

With a major grant, family medicine physicians at UB are forming a council that will develop curricula and national standards of excellence for postgraduate medical education programs in addiction medicine.

5/31/11

UB’s addiction medicine residency is one of the first of its kind to be accredited by the American Board of Addiction Medicine Foundation.